A detailed history of Blackston Financial Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Blackston Financial Advisory Group, LLC holds 936 shares of AMGN stock, worth $265,842. This represents 0.16% of its overall portfolio holdings.

Number of Shares
936
Previous 848 10.38%
Holding current value
$265,842
Previous $264,000 14.02%
% of portfolio
0.16%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $27,225 - $29,689
88 Added 10.38%
936 $301,000
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $222,812 - $270,774
848 New
848 $264,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $6,990 - $8,438
-26 Reduced 2.61%
972 $276,000
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $36,309 - $40,961
-142 Reduced 12.46%
998 $287,000
Q3 2023

Jan 26, 2024

BUY
$218.65 - $271.46 $36,951 - $45,876
169 Added 16.93%
1,167 $313,000
Q2 2023

Jul 19, 2023

SELL
$214.27 - $253.37 $119,776 - $141,633
-559 Reduced 32.9%
1,140 $253,000
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $13,095 - $15,961
58 Added 3.53%
1,699 $411,000
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $10,764 - $13,677
47 Added 2.95%
1,641 $431,000
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $17,732 - $19,998
-79 Reduced 4.72%
1,594 $431,000
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $385,977 - $429,526
1,673 New
1,673 $414,000
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $317,502 - $351,241
-1,448 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $287,978 - $329,564
1,448 New
1,448 $326,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Blackston Financial Advisory Group, LLC Portfolio

Follow Blackston Financial Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackston Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blackston Financial Advisory Group, LLC with notifications on news.